A time-tradeoff method for cost-effectiveness models applied to radiology

Medical Decision Making

Volumn 20, Issue 1, 2000, Pages 79-88

  Swan, J Shannon ^a,e   Fryback, Dennis G ^b,c   Lawrence, William F ^d   Sainfort, FRANÇOIS ^b,c   Hagenauer, Mary Ellen ^b   Heisey, Dennis M ^b  

^a INDIANA UNIVERSITY   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c GEORGETOWN UNIVERSITY   (United States)

^d GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e INDIANA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Angiography; Cost effectiveness; Magnetic resonance; Technology assessment; Time tradeoff; Utility assessment

Indexed keywords

ADULT; AGED; AMBIVALENCE; ANGIOGRAPHY; ARTICLE; ATHEROSCLEROSIS; BIOMEDICAL TECHNOLOGY ASSESSMENT; CLINICAL ARTICLE; COST EFFECTIVENESS ANALYSIS; FEMALE; HEALTH STATUS; HUMAN; INTERVIEW; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MEDICAL DECISION MAKING; PERIPHERAL VASCULAR DISEASE; QUALITY ADJUSTED LIFE YEAR; RADIODIAGNOSIS; X RAY;

EID: 0033989111     PISSN: 0272989X     EISSN: None     Source Type: Journal    
DOI: 10.1177/0272989X0002000110     Document Type: Article

References (24)

1. Gold MR, Russell L, Siegel JE, Weinstein MC (eds). Cost Effectiveness in Health and Medicine. New York: Oxford University Press, 1996.
2. von Neumann J, Morgenstern O. Theories of Games and Economic Behavior. Princeton, NJ: Princeton University Press, 1947.
3. Torrance GW, Thomas WH, Sackett DL. A utility maximization model for evaluation of health care programs. Health Serv Res. 1972;7:118-33.
4. Drummond MF, Stoddart CL, Torrance GW. Cost-utility analysis. In: Methods for the Economic Evaluation of Health-Care Programs. Oxford, U.K.: Oxford University Press, 1987.
5. Jansen SJT, Stiggelbout AM, Wakker PP, et al. Patients' utilities for cancer treatments: a study of the chained procedure for the standard gamble and time tradeoff. Med Decis Making. 1998;18:391-9.
6. Swan JS, Fryback DG, Lawrence WL, et al. MR and conventional angiography: work in progress toward assessing utility in radiology. Acad Radiol. 1997;4:475-82.
7. Katz DA, Cohen BJ. Temporary treatment-related health states in decision analytic models: is the full burden of morbidity being captured? [abstr]. Med Decis Making. 1995;15: 415A.
8. Cochran ST, Wong WS, Roe DJ. Predicting angiography-induced acute renal function impairment: clinical risk model. Am J Radiol. 1983;141:1027-33.
9. Prince MR, Yucel EK, Kaufman JA, Harrison DC, Geller SC. Dynamic gadolinium-enhanced three-dimensional abdominal MR arteriography. JMRI 1993:3:877-881.
10. Prince MR, Arnoldus C, Frisoli JK. Nephrotoxicity of high-dose gadolinium compared with iodinated contrast. J Magn Resn Imaging. 1996;1:162-6
11. Murphy KJ, Brumberg JA, Cohan DH. Adverse reactions to gadolinium contrast media: a review of 36 cases. Am J Radiol. 1996;167:847-9.
12. Hunink MGM, Wong JB, Donaldson MC, Meyerovitz MF, deVries J, Harrington DP. Revascularization for femoropopliteal disease: a decision and cost-effectiveness analysis. JAMA. 1995;274:165-71.
13. Fryback DF, Dasbach EJ, Klein R, et al. The Beaver Dam Health Outcomes Study: initial catalog of health-state quality functions. Med Decis Making. 1993;13:89-102.
14. Kahneman D, Wakker P. Back to Bentham? Explorations of experienced utility. Q J Econ. 1997;112:375-404.
15. Ariely D. Combining experiences over time: the effects of duration, intensity changes and on-line measurements on retrospective pain evaluations. J Behav Decis Making. 1998;11: 19-45.
16. Slevin ML, Stubbs L, Plant HJ. Attitude to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public. BMJ. 1990;300:1458-60.
17. Gabriel SE, Kneeland TS, Melton LJ, Moncur MM, Ettinger B, Tosteson ANA. Health-related quality of life in economic evaluations for osteoporosis: whose values should we use? Med Decis Making. 1999;19:141-8.
18. DeVries SO, Kuipers WD, Hunink MGM. Intermittent claudication: symptom severity versus health values. J Vasc Surg. 1998;27:422-30.
19. Yin D, Baum RA, Carpenter JP, Langlotz CP, Pentecost MJ. Cost-effectiveness of MR angiography in cases of limb-threatening peripheral vascular disease. Radiology. 1995;194: 757-64.
20. Prince MR, Narasimham DL, Stanley JC, et al. Gadolinium-enhanced magnetic resonance angiography of abdominal aortic aneurysms. J Vasc Surg. 1995;21:656-69.
21. Hany TF, Debatin JF, Leung DA, Pfammatter T. Evaluation of the aorto-iliac and renal arteries: comparison of breath-hold, contrast-enhanced, three-dimensional MR angiography with conventional catheter angiography. Radiology. 1997;204:357-62.
22. Kaplan RM, Anderson JP, Ganiats TG. The Quality-of-Well-Being Scale: rationale for a single quality of life index. In: Walker SR, Rosser RM (eds). Quality of Life Assessment: Key Issues in the 1990's. Norwell, MA: Kluver Academic, 1993;65-94.
23. Goldman L, Gordon DJ, Rifkind BM, et al. Cost and health implications of cholesterol lowering. Circulation. 1992;85: 1960-8.
24. Gold MR, Patrick DL, Torrance GW, et al. Identifying and valuing outcomes. In: Gold MR, Russell L, Siegel JE, Weinstein MC (eds). Cost Effectiveness in Health and Medicine. New York: Oxford University Press, 1996:82-134.